Sandoz, the generics and biosimilars arm of Novatris, has announced its three finalists in its competition for digital technologies which improve access to medicines in poorer countries.
As part of the competition (known as Sandoz HACk) the finalists will take part in an accelerator event where they will work with Sandoz to refine their ideas. The competition is running for its second year, this year receiving more than 400 entries.
The three finalists this year include:
- Regulora: prescription-only digital therapeutic based on Gut Directed Hypnotherapy for patients with Irritable Bowel Syndrome. The mobile app connects patients to automated therapy sessions and also with daily practice routines.
- Social Genomics: AI based smart social network enabling people with rare and undiagnosed conditions to connect and share stories. By using advanced matchmaking, Social Genomics aims to link the right questions to the right people and data sources.
- Mobile Clinic: developed for the challenging antenatal and maternal care environment of Uganda, Mobile Clinic aims to develop an app which can be used to make emergency appointments via a toll-free number. The app will be directly linked to a mobile clinic offering door-to-door services.
The winner of the competition will receive seed funding and support from Sandoz to help them bring their idea to life.